Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
17.22 USD | +4.55% | +9.61% | +14.17% |
02/05 | NovoCure Shares Steady After Reporting Narrower Q1 Loss, Higher Revenue | MT |
02/05 | BioPharma Credit Enters $400 Million Loan Agreement with Novocure Luxembourg | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.17% | 1.77B | |
+73.56% | 12.41B | |
-16.79% | 8.23B | |
+3.44% | 6.46B | |
+14.69% | 5.5B | |
-5.22% | 5.33B | |
+40.80% | 5.1B | |
-18.32% | 4.05B | |
-28.11% | 2.54B | |
+7.56% | 1.99B |
- Stock Market
- Equities
- NVCR Stock
- News NovoCure Limited
- Wedbush Upgrades NovoCure to Neutral From Underperform After Additional Details From LUNAR Study, Notes Limited Near-Term Catalysts; Lowers PT to $46 From $53